Leo Corrigan III
CIK 1256942 · View on SEC EDGAR ↗
First SEC filing: May 19, 2005 · Latest: May 19, 2005
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 4, 2004 | TCBIO | P | 4,900 | $15.30 | $74,970 | 33,000 Indirect | +17.44% | Acquired | 35.0% (price as of 2026-08-21) |
| June 3, 2004 | TCBIO | P | 5,000 | $15.25 | $76,250 | 28,100 Indirect | +21.65% | Acquired | 35.5% (price as of 2026-08-21) |
| June 2, 2004 | TCBIO | P | 5,100 | $15.12 | $77,112 | 23,100 Indirect | +28.33% | Acquired | 36.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 24, 2007 | TCBIO | Stock Appreciation Rights | Common Stock (2,000) | $22.47 | July 24, 2017 | 2,000 | Acquired |
| May 16, 2006 | TCBIO | Restricted Stock Units | Common Stock (100) | — | — | 100 | Disposed |
| May 16, 2006 | TCBIO | Stock Appreciation Rights | Common Stock (2,000) | $23.00 | May 16, 2016 | 2,000 | Acquired |
| May 16, 2006 | TCBIO | Restricted Stock Units | Common Stock (500) | — | — | 500 | Acquired |
| May 17, 2005 | TCBIO | Common Stock Options | Common Stock (4,000) | $19.37 | May 17, 2015 | 4,000 | Acquired |
| May 18, 2004 | TCBIO | Common Stock Options | Common Stock (4,000) | $14.91 | May 18, 2014 | 4,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).